Hypothesis

2 Matching Annotations

Last 7 days
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Immunomodulation of Pancreatic Cancer via Inhibition of SUMOylation and CD155/TIGIT Pathway

1
1. scibot 20 May 2026
  
  in Public
  
  RRID:AB_905958
  
  DOI: 10.1158/1535-7163.MCT-25-0129
  
  Resource: (Bio-Rad Cat# MCA2691, RRID:AB_905958)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_905958
  
  What is this?
  
  RRID:AB_905958
Visit annotations in context

Tags

RRID:AB_905958

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13174929/
Jun 2025
www.sciencedirect.com www.sciencedirect.com

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models

1
1. scibot 13 Jun 2025
  
  in Public
  
  RRID:AB_905958
  
  DOI: 10.1016/j.ccell.2025.05.014
  
  Resource: None
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_905958
  
  What is this?
  
  RRID:AB_905958
Visit annotations in context

Tags

RRID:AB_905958

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610825002235